Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.66
-0.13 (-1.67%)
At close: May 15, 2026, 4:00 PM EDT
7.67
0.00 (0.07%)
After-hours: May 15, 2026, 4:10 PM EDT
Grifols Employees
Grifols had 25,247 employees as of December 31, 2025. The number of employees increased by 1,425 or 5.98% compared to the previous year.
Employees
25,247
Change (1Y)
1,425
Growth (1Y)
5.98%
Revenue / Employee
$339,686
Profits / Employee
$18,953
Market Cap
6.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 25,247 | 1,425 | 5.98% |
| Dec 31, 2024 | 23,822 | 85 | 0.36% |
| Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
| Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
| Dec 31, 2021 | 23,234 | -421 | -1.78% |
| Dec 31, 2020 | 23,655 | -348 | -1.45% |
| Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
| Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
| Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
| Dec 31, 2016 | 14,877 | 140 | 0.95% |
| Dec 31, 2015 | 14,737 | 757 | 5.41% |
| Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
| Dec 31, 2013 | 11,779 | 671 | 6.04% |
| Dec 31, 2012 | 11,108 | -122 | -1.09% |
| Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
| Dec 31, 2010 | 5,968 | -16 | -0.27% |
| Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Merck & Co. | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| GSK plc | 66,841 |
| Bristol-Myers Squibb Company | 32,500 |
| Amgen | 31,500 |
| Gilead Sciences | 17,000 |
GRFS News
- 2 days ago - Insider Buying: Donald Tyler Acquires Shares of Eagle Capital Growth Fund Inc (GRF) - GuruFocus
- 3 days ago - Grifols price target lowered to EUR 10 from EUR 11 at Deutsche Bank - TheFly
- 7 days ago - Q1 2026 Grifols SA Earnings Call Transcript - GuruFocus
- 8 days ago - Grifols reports Q1 adjusted EBITDA EUR 381M, up 0.8% cc - TheFly
- 8 days ago - Grifols says Q1 results support FY26 guidance - TheFly
- 8 days ago - Grifols Q1 Profit Rises - Nasdaq
- 6 weeks ago - New conditions imposed on Grifols by Health Canada, CBC News reports - TheFly
- 6 weeks ago - Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates - GlobeNewsWire